ABCL — ABCELLERA BIOLOGICS INC

Ownership history in nVerses Capital, LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which nVerses Capital, LLC reported a position in ABCELLERA BIOLOGICS INC (ABCL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.27% (2025 Q4)
Avg. % of fund
0.14%
First filed
2024 Q1
Last filed
2025 Q4
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 35,446 +34,346 +3122.4% 0.27% $121K $3.42
2024 Q1 INITIATED 1,100 — — 0.01% $5K —
% of Fund (quarterly)    ABCL price (monthly, adj. close)

Other funds also holding ABCL

As of 2025 Q4 — sorted by position size

BAKER BROS. ADVISORS LP 3Y 7Y 0.55% Guardian Partners Inc. 0.47% Intellectus Partners, LLC 3Y 7Y 0.35% ArrowMark Colorado Holdings LLC 3Y 7Y 0.31% ArchPoint Investors 3Y 7Y 0.09% DRIEHAUS CAPITAL MANAGEMENT LLC 3Y 7Y 0.09% Green Alpha Advisors, LLC 3Y 0.09% PIER 88 INVESTMENT PARTNERS LLC 3Y 7Y 0.08% Virtus Investment Advisers, LLC 3Y 7Y 0.07% Resolute Advisors LLC 3Y 0.06%
← Back to nVerses Capital, LLC Holdings